skip to main content
Idioma:
Refinado por: assunto: Isquemia Miocárdica remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Alirocumab reduces total hospitalizations and increases days alive and out of Hospital in the ODYSSEY OUTCOMES Trial
Alirocumab reduces total hospitalizations and increases days alive and out of Hospital in the ODYSSEY OUTCOMES Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Alirocumab reduces total hospitalizations and increases days alive and out of Hospital in the ODYSSEY OUTCOMES Trial

Michael Szarek Ph. Gabriel Steg; Dina Dicenso; Deepak L Bhatt; Vera A Bittner; Andrzej Budaj; Rafael Diaz; Shaun G Goodman; Nina Gotcheva; José Carlos Nicolau

Circulation-cardiovascular quality and outcomes v. 12, n. 11, 2019

Philadelphia 2019

Acesso online. A biblioteca também possui exemplares impressos.

2
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

Matthew T Roe Qian H Li; Deepak L Bhatt; Vera A Bittner; Rafael Diaz; Shaun G Goodman; Robert A Harrington; J. Wouter Jukema; Patricio Lopez-jaramillo; José Carlos Nicolau

Circulation v. 140, n. 19, p. 1578-1589, 2019

Philadelphia 2019

Acesso online. A biblioteca também possui exemplares impressos.

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.